Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target KG Arun, CS Sharanya, J Abhithaj, D Francis, C Sadasivan Journal of Biomolecular Structure and Dynamics 39 (13), 4647-4658, 2021 | 57 | 2021 |
Streptococcus pneumoniae surface protein PfbA is a versatile multidomain and multiligand‐binding adhesin employing different binding mechanisms DSJ Beulin, D Radhakrishnan, SC Suresh, C Sadasivan, M Yamaguchi, ... The FEBS Journal 284 (20), 3404-3421, 2017 | 15 | 2017 |
Repurposing simeprevir, calpain inhibitor IV and a cathepsin F inhibitor against SARS-CoV-2 and insights into their interactions with Mpro. D Francis, EJ Variyar Journal of Biomolecular Structure & Dynamics, 1-12, 2020 | 12 | 2020 |
Potent phytochemicals against COVID-19 infection from phyto-materials used as antivirals in complementary medicines: a review CS Sharanya, A Sabu, M Haridas Future Journal of Pharmaceutical Sciences 7 (1), 1-20, 2021 | 8 | 2021 |
Inhibitory activity of hibifolin on adenosine deaminase- experimental and molecular modeling study AKCSSSPMC Sadasivan Computational biology and chemistry, 2016 | 8 | 2016 |
Drug repurposing to identify therapeutics against COVID 19 with SARS-Cov-2 spike glycoprotein and main protease as targets: an in silico study CS Sharanya, J Abhithaj, C Sadasivan | 7 | 2020 |
Computational and experimental validation of morin as adenosine deaminase inhibitor KG Arun, CS Sharanya, C Sadasivan Journal of Receptors and Signal Transduction 38 (3), 240-245, 2018 | 7 | 2018 |
Designing of enzyme inhibitors based on active site specificity: lessons from methyl gallate and its lipoxygenase inhibitory profile. HM CS Sharanya, KG Arun, V Vijaytha, Sabu A J Recept Signal Transduct Res, 1-10, 2018 | 6* | 2018 |
Designing of enzyme inhibitors based on active site specificity: lessons from methyl gallate and its lipoxygenase inhibitory profile S CS, A KG Journal of Receptors and Signal Transduction 38 (3), 256-265, 2018 | 6 | 2018 |
Aloe emodin shows high affinity to active site and low affinity to two other sites to result consummately reduced inhibition of lipoxygenase CS Sharanya, KG Arun, A Sabu, M Haridas Prostaglandins & Other Lipid Mediators 150, 106453, 2020 | 5 | 2020 |
Plant metabolomics: current status and prospects CS Sharanya, A Sabu, M Haridas Plant metabolites: methods, applications and prospects, 1-22, 2020 | 4 | 2020 |
Biochemical and computational insights of adenosine deaminase inhibition by Epigallocatechin gallate KG Arun, CS Sharanya, J Abhithaj, C Sadasivan Computational Biology and Chemistry 83, 107111, 2019 | 4 | 2019 |
Repurposing Simeprevir, Calpain Inhibitor IV and a Cathepsin F Inhibitor Against SARS-CoV-2: A Study Using in Silico Pharmacophore Modeling and Docking Methods J Abhithaj, D Francis, CS Sharanya, C Sadasivan, J Variyar | 3 | 2020 |
Isozymes inhibited by active site blocking: versatility of calcium indifferent hesperidin binding to phospholipase A2 and its significance J Abhithaj, KG Arun, CS Sharanya, M Haridas, E Jayadevi Variyar Journal of Receptors and Signal Transduction 39 (1), 60-66, 2019 | 2 | 2019 |
Implication of biotransformation of berberine and its derivatives on FtsZ protein: an in silico study DN Chandra, CS Suresh, GA Kumar, PM Sandeep, A Sabu, M Haridas International Journal of Computational Biology and Drug Design 10 (1), 1-11, 2017 | 2 | 2017 |
In silico and in vitro validation of some benzimidazole derivatives as adenosine deaminase inhibitors A Kumar G, S CS Indian Journal of Chemistry-Section B (IJC-B) 59 (8), 1175-1182, 2020 | 1 | 2020 |
Drug repurposing for COVID-19 from FDA approved and experiment stage drugs by in silico methods with SARS CoV-2 spike protein CS Sharanya, J Abhithaj, A Sabu, H Madathilkovilakathu | 1 | 2020 |
Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening and molecular docking with main protease as the target CS Sharanya, J Abhithaj, D Francis, C Sadasivan | 1 | 2020 |
Repurposing of Streptomyces antibiotics as adenosine deaminase inhibitors by pharmacophore modeling, docking, molecular dynamics, and in vitro studies KG Arun, CS Sharanya, J Abhithaj, C Sadasivan Journal of Receptors and Signal Transduction 40 (1), 77-88, 2020 | 1 | 2020 |
Fermentation of poly herbal preparations as in Ayurveda: a novel protocol for drug lead discovery CS Sharanya, H Shabeer Ali, A Sabu, M Haridas J Nat Ayurvedic Med 3 (3), 1-8, 2019 | 1 | 2019 |